Avenzo Therapeutics

Manufacturing · California, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

12707 High Bluff Dr Ste 200, San Diego, ...

Phone Number

(858) 239-2944

Revenue

$10.6 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1

About Avenzo Therapeutics

Avenzo Therapeutics is a biotechnology company focused on developing innovative therapies to treat solid tumor cancers, aiming to improve outcomes for cancer patients through cutting-edge science and clinical research.Explore more
Avenzo Therapeutics's Social MediaPopular SearchesAvenzo Therapeutics IncAvenzo TherapeuticsSIC Code 28,283NAICS Code 32,325Show more

Avenzo Therapeutics Org Chart

PhoneEmail
Scott Lipman, Chief Business Officer & Chief Financial Officer at Avenzo Therapeutics
United States flag for contact location.

Chief Business Officer & Chief Financial Offi...

PhoneEmail
Mohammad Hirmand, Co-founder, Executive VP & Chief Medical Officer at Avenzo Therapeutics
United States flag for contact location.

Co-founder, Executive VP & Chief Medical Offi...

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
CH
United States flag for contact location.

Vice President Head of Financial Planning & A...

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Avenzo Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Avenzo Therapeutics

Compare insights from companies similar to Avenzo Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Avenzo Therapeutics

$10.6M
11-50
Private
$487.2M
2022
Scott Lipman, Chief Business Officer & Chief Financial Officer at Avenzo Therapeutics
Scott LipmanChief Business Officer & Chief Financial Officer
$16.3M
11-50
Private
$151M
2019
KK
Katherine Kayser-BrickerChief Scientific Officer
$5.1M
11-50
Private
$24.4M
2021
RK
Robin KleimanChief Scientific Officer
<$5M
11-50
Private
$50M
2022
N/A
<$5M
11-50
Private
$178M
2023
<$5M
1-10
Private
-
-
Stephanie Cherqui, Co-Founder & Director, Board of Member at Papillon Therapeutics
Stephanie CherquiCo-Founder & Director, Board of Member
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Avenzo Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Avenzo Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Avenzo Therapeutics.

Avenzo Therapeutics financials insights

Gather financial insights about Avenzo Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2024

Series A

$380M

2025

Private Equity

$47.2M

Series B

$60M

See All Avenzo Therapeutics's Financials Insights

Avenzo Therapeutics Tech Stack

A closer look at the technologies used by Avenzo Therapeutics

Most Recent Scoops

Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
Open Position
Open Position
Open Position
See more scoops

Avenzo Therapeutics News & Media

Read more news

Top Manufacturing Companies

Frequently Asked Questions Regarding Avenzo Therapeutics

What is Avenzo Therapeutics's official website?
Avenzo Therapeutics's official website is www.avenzotx.com
What is Avenzo Therapeutics's Revenue?
Avenzo Therapeutics's revenue is $10.6 Million
What is Avenzo Therapeutics's SIC code?
Avenzo Therapeutics's SIC: 28,283
What is Avenzo Therapeutics's NAICS code?
Avenzo Therapeutics's NAICS: 32,325
How many employees does Avenzo Therapeutics have?
Avenzo Therapeutics has 11-50 employees
What industry does Avenzo Therapeutics belong to?
Avenzo Therapeutics is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Avenzo Therapeutics competition?
Avenzo Therapeutics top competitors include: Shinobi Therapeutics, Halda Therapeutics, Papillon Therapeutics, Arnatar
What companies has Avenzo Therapeutics acquired?
Avenzo Therapeutics has acquired the companies: Candid Therapeutics, Avenzo Therapeutics, Celltech Group, Oxford GlycoSciences
What technology does Avenzo Therapeutics use?
Some of the popular technologies that Avenzo Therapeutics uses are: WordPress.org, reCAPTCHA, PHP, Cloudflare CDN
Who is the CFO of Avenzo Therapeutics?
Avenzo Therapeutics's CFO is Scott Lipman
How do I contact Avenzo Therapeutics?
Avenzo Therapeutics contact info: Phone number: (858) 239-2944 Website: www.avenzotx.com
What does Avenzo Therapeutics do?

Avenzo Therapeutics is a biotechnology company focused on developing innovative therapies to treat solid tumor cancers, aiming to improve outcomes for cancer patients through cutting-edge science and clinical research.... Read More

What are Avenzo Therapeutics social media links?
Avenzo Therapeutics Linkedin page
Who invested in Avenzo Therapeutics?
Avenzo Therapeutics has 14 investors including New Enterprise Associates, Sofinnova, Sands Capital and Deep Track Capital.
Is Avenzo Therapeutics a public company?
Avenzo Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Avenzo Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.